Astros fan in remission from ovarian cancer attends home-opener. Last April, Janie Morris learned she had stage 3 ovarian cancer. Doctors discovered it on Morris' birthday. khou.com/article/sports/astr…
1
Is TapImmune’s cancer vaccine (TPIV200) the real deal? Vaccine being tested against ovarian & breast cancer. medcitynews.com/2018/03/tapi…
Stable Disease w/Tumor Shrinkage Reported in Subject 2 Following Single IP Dose of NK100 (allogeneic donor-derived natural killer (NK) cell cancer immunotherapy). ir.fatetherapeutics.com/news…
Only Certain Gynecologic Malignancies Benefit from Immunotherapy. #SGO2018 curetoday.com/articles/only-…
Women with Recurrent Ovarian Cancer Should Be Screened for Various Biomarkers. curetoday.com/articles/women…
PARP-7 Amplification Mutations Linked to Prolonged Survival in Ovarian Cancer. #SGO2018 cancernetwork.com/sgo/parp-7…
Pembrolizumab (Keytruda) + pegylated liposomal doxorubicin (PLD) produced a RR of 19% & a CBR of 43% in pts w/ recur plat-resist ovarian cancer. #SGO2018 medpagetoday.com/meetingcove…
The Role of Fluid Flow in Ovarian Cancer Progression. technologynetworks.com/cance…
Chlamydia Infection is Associated With Increased Risk of Ovarian Cancer. #AACR2018 aacr.org/Newsroom/Pages/News…
Repurposing Existing FDA-Approved (HDAC) Inhibitors May Provide New Treatment Approach for ARID1A-mutated ovcrs like ovarian clear cell cancer. wistar.org/news/press-releas…
Women Do Well Without Opioids after Gyn Surgery -- 89% drop in opioid use w/restrictive prescribing protocol. #SGO2018 medpagetoday.com/meetingcove…
Federal funding for medical research severely short changes gynecologic oncology when cancer lethality is taken into account. #SGO2018 medpagetoday.com/meetingcove…
Promise Seen With Frontline Pembrolizumab + Chemo in Ovarian Cancer. #SGO2018 targetedonc.com/news/promise…
Safety Analysis Favors Olaparib in Meta-Analysis Comparing PARP Inhibitors in Ovarian Cancer. #SGO2018 targetedonc.com/conference/s…
Baylor & M.D. Anderson discover a mutant protein, called p53-R175H, linked to ovarian cancer. medicalxpress.com/news/2018-…
PARP + PD-1/PD-L1 inhibition active in plat-resist & plat-sensitive ovarian cancer pts, w/DCR as high as 72%. #SGO medpagetoday.com/meetingcove…
An Overview of Vigil Personalized Engineered Autologous Tumor Cells in Ovarian Cancer. #SGO2018 youtube.com/watch?time_conti…
Early Biomarkers Found for Patients Requiring Dose Reduction With Niraparib in Ovarian Cancer. #SGO2018 targetedonc.com/conference/s…
Higher Toxicity With Checkpoint Inhibitor Treatment Found in Study of Recurrent Ovarian Cancer. #SGO2018 targetedonc.com/conference/s…
Predicting Response to PARP Inhibitor Therapy in Ovarian Cancer. #SGO2018 targetedonc.com/conference/s…
